Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

December 31, 2004

Conditions
Lung Cancer
Interventions
BIOLOGICAL

EP-2101

BIOLOGICAL

incomplete Freund's adjuvant

Trial Locations (9)

12208

New York Oncology Hematology, P. C. at Albany Regional Cancer Care, Albany

27710

Duke Comprehensive Cancer Center, Durham

29615

Cancer Centers of the Carolinas - Eastside, Greenville

34761

Cancer Centers of Florida - Ocoee, Ocoee

37203

Sarah Cannon Cancer Center at Centennial Medical Center, Nashville

45409

Dayton Oncology & Hematology, P.A. - Kettering, Kettering

75246

Mary Crowley Medical Research Center at Sammons Cancer Center, Dallas

75702

Tyler Cancer Center, Tyler

99218

Cancer Care Northwest - North, Spokane

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Epimmune

INDUSTRY

NCT00104780 - Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter